+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

APC gene loss of heterozygosity, mutations, E1317Q, and I1307K germ-line variants in sporadic colon cancer in Croatia



APC gene loss of heterozygosity, mutations, E1317Q, and I1307K germ-line variants in sporadic colon cancer in Croatia



Experimental and Molecular Pathology 77(3): 193-200



Colorectal carcinomas are characterized by multiple genetic aberrations that occur during tumorigenesis. Several tumor suppressor genes associated with colorectal carcinoma have been identified: MCC, APC, p53, nm23-H1, DCC, DPC4. We examined 73 cases of sporadic human colon cancer and corresponding normal tissue samples to evaluate the loss of heterozygosity (LOH) at the APC gene loci. The purpose of this study was also to evaluate whether the LOH at the APC gene is associated with clinicopathological characteristics in sporadic colon cancer. We also investigated presence and the frequency of the most common APC gene mutations and APC E1317Q and I1307K germ-line variants in Croatian colorectal cancer patients. Five markers in all patients were found to be heterozygous and informative for LOH analysis. LOH at the APC locus was detected in 30.1% of tumors were examined. The majority of APC gene LOH was observed in Dukes' B (55.6%) and in the moderately differentiated tumors (42.9%). Only 1309 APC gene mutation was detected in our samples. In one tumor sample, a new sporadic mutation of the APC gene in codon 1374 was detected. APC E1317Q and I1307K germ-line variants were not detected in our population. But APC E1317Q sporadic mutation was found in one tumor sample.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011716390

Download citation: RISBibTeXText

PMID: 15507235

DOI: 10.1016/j.yexmp.2004.06.001


Related references

APC I1307K and the E1317Q variants are not present in Chinese colorectal cancer patients. Genetics in Medicine 6(4): 237-238, 2004

Apc I1307K and the E1317Q variants are not present in Chinese colorectal cancer patients. Genetics in Medicine 6(4): 237-238, 2004

APC I1307K and E1317Q variants are rare or do not occur in Swedish colorectal cancer patients. European Journal of Cancer 37(4): 499-502, 2001

NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancer. Gut 54(8): 1129-1135, 2005

DPC4 tumor suppressor gene in human sporadic colon cancer; loss of heterozygosity. European Journal of Human Genetics 9(Suppl. 1): P0123, 2001

Loss of heterozygosity of DPC4 tumor suppressor gene in human sporadic colon cancer. Journal of Molecular Medicine 79(2-3): 128-132, 2001

The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history. Proceedings of the National Academy of Sciences of the United States of America 95(18): 10722-10727, 1998

Evidence for an association between compound heterozygosity for germ line mutations in the hemochromatosis (HFE) gene and increased risk of colorectal cancer. Cancer Epidemiology Biomarkers and Prevention 14(6): 1460-1463, 2005

Loss of heterozygosity and mutations of von-Hippel-Lindau gene on sporadic cerebellar hemangioblastoma. Proceedings of the American Association for Cancer Research Annual Meeting 38: 536, 1997

Loss of heterozygosity of APC and DCC tumor suppressor genes in human sporadic colon cancer. Journal of Molecular Medicine 77(3): 316-321, 1999

Loss of heterozygosity and mutations are the major mechanisms of RB1 gene inactivation in Chinese with sporadic retinoblastoma. Human Mutation 20(5): 408, 2002

Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas. Cancer Research 58(3): 504-508, 1998

Sporadic pituitary adenomas show loss of heterozygosity in 11q13 without mutations in the MEN1 gene. Journal of Endocrinological Investigation 23(6 Suppl ): 9, 2000

Neurofibromatosis 2 phenotypes and germ-line NF2 mutations determined by an RNA mismatch method and loss of heterozygosity analysis in NF2 schwannomas. Cancer Genetics & Cytogenetics 118(2): 167-168, 2000

Analysis of MSH2 Loss of Heterozygosity, Expression, and IVS10+12G>A Polymorphism in Sporadic Colon Cancer. Anticancer Research 38(5): 2841-2848, 2018